Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $200 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, pharmaceuticals
Related Tickers: CPRX
TL;DR
CATALYST PHARMACEUTICALS FILED AN 8-K ON 10/1/25. CHECK FOR UPDATES.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on October 1, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is based in Coral Gables, Florida, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates Catalyst Pharmaceuticals is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing reporting corporate events and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- October 1, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Coral Gables, Florida (location) — Principal Executive Offices
- 001-33057 (identifier) — SEC File Number
FAQ
What specific 'Other Events' are being reported by Catalyst Pharmaceuticals in this 8-K?
The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the provided text snippet.
What is the SIC code for Catalyst Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Catalyst Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
When was Catalyst Pharmaceuticals, Inc. previously known as Catalyst Pharmaceutical Partners, Inc.?
The company was formerly known as Catalyst Pharmaceutical Partners, Inc. with a date of name change on February 15, 2011.
What is the fiscal year end for Catalyst Pharmaceuticals?
The fiscal year end for Catalyst Pharmaceuticals is December 31 (1231).
What is the primary exchange where Catalyst Pharmaceuticals' stock is traded?
Catalyst Pharmaceuticals' stock is traded on NASDAQ, as indicated by the filing.
Filing Stats: 539 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-10-01 16:31:13
Key Financial Figures
- $0.001 — Ticker Symbol Common Stock, par value $0.001 per share NASDAQ Capital Market CPR
- $200 million — orizing the Company to repurchase up to $200 million of its common stock between October 1,
Filing Documents
- d118298d8k.htm (8-K) — 25KB
- d118298dex991.htm (EX-99.1) — 7KB
- 0001193125-25-226837.txt ( ) — 148KB
- cprx-20251001.xsd (EX-101.SCH) — 3KB
- cprx-20251001_lab.xml (EX-101.LAB) — 18KB
- cprx-20251001_pre.xml (EX-101.PRE) — 11KB
- d118298d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued by the Company on October 1, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Catalyst Pharmaceuticals, Inc. By: /s/ Michael W. Kalb Michael W. Kalb Executive Vice President and Chief Financial Officer Dated: October 1, 2025 3